ReviewEndocrine2020
Prevalence of gastrointestinal disorders having an impact on tablet levothyroxine absorption: should this formulation still be considered as the first-line therapy?
Marco Castellana et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
21 papers cite it
this paperpooled itcites it